contact us
Ironwood Pharmaceuticals (IRWD +7.5%) is up on below-average volume following the news that it has hired former AstraZeneca (AZN +2.2%) strategy chief Mark Mallon as its new CEO.
Do Not Allow Advertisers to Use My Personal information
